We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.
Each day, our employees around the world work together for patients – patients are at the center of everything we do. They inspire us. They are the reason we come to work each day.
We are proud of the advancements we have made in oncology, hematology, immunology and cardiovascular disease, and we are dedicated to helping patients prevail over serious diseases through our diverse and promising pipeline and new scientific platforms.
We are pursuing therapies at the forefront of scientific discovery with the goal of bringing an exciting new generation of life-changing treatments to patients. We aspire to be at the center of a vibrant healthcare innovation ecosystem, where academic research centers, biotech and biopharma companies all contribute to continued scientific advancement.
At BMS, we are also committed to creating a workforce that represents inclusion, equality and authenticity in our everyday lives -- at work and at home. BMS has built a work environment where our employees are encouraged to bring their true selves to work and to contribute in a unique and meaningful way to our mission. Our commitment to employees means we embrace a diverse workforce and inclusive culture. We are accountable to one another and to the patients we serve.
Innovation is vital to addressing the most important challenges in life. Through partnerships with researchers, physicians, and patient groups we are able to apply insights-based innovation and help to elevate patient care. At BMS Canada, we are proud of the journey our innovations take, from bench to bedside.
About Bristol Myers Squibb Canada
As a leading biopharma company in Canada, BMS is committed to scientific excellence and continued investment in R&D. BMS combines the agility of a biotech with the reach and resources of an established pharmaceutical company.
In oncology, hematology, immunology and cardiovascular disease – and with one of the most diverse and promising pipelines in the industry – we focus on innovations that drive meaningful change.
BMS established roots in Canada in 1925 and has become a recognized pharmaceutical company with breakthroughs that advanced the treatment of serious diseases affecting Canadians. We have a history of scientific excellence, transforming patient outcomes in major diseases such as cancer, cardiovascular disease, HIV and Hepatitis C.
Across Canada and the world, we are making improvements in disease states and we are finding new ways to treat challenging diseases that will significantly impact patients.
Canada is a world leading destination to conduct early development studies including first-in-human trials. In 2020, BMS had the second highest number of active clinical trials amongst the top 20 pharmaceutical companies in Canada.
We are united in our relentless quest to deliver revolutionary patient care solutions so Canadians can live healthier and longer lives.